
Cytosorbents Crp is a medical devices business based in the US. Cytosorbents Crp shares (CTSO) are listed on the NASDAQ and all prices are listed in US Dollars. Cytosorbents Crp employs 221 staff and has a trailing 12-month revenue of around $36.1 million.
How to buy Cytosorbents Crp stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – CTSO. It's that simple.
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
Robinhood
- Get free stock upon signup
- Earn 4% interest on uninvested cash with Robinhood Gold
- Get 1% match on contributions to a Robinhood IRA
tastyworks
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.
Cytosorbents Crp stock price (NASDAQ: CTSO)
Use our graph to track the performance of CTSO stocks over time.Cytosorbents Crp shares at a glance
Latest market close | $2.37 |
---|---|
52-week range | $1.03 - $4.15 |
50-day moving average | $1.54 |
200-day moving average | $1.90 |
Wall St. target price | $9.00 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-0.68 |
Buy Cytosorbents Crp stocks from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Cytosorbents Crp stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Cytosorbents Crp price performance over time
Historical closes compared with the close of $2.37 from 2023-01-27
1 week (2023-01-23) | 10.75% |
---|---|
1 month (2022-12-30) | 52.90% |
3 months (2022-10-28) | 36.21% |
6 months (2022-07-29) | 3.95% |
1 year (2022-01-28) | -32.09% |
---|---|
2 years (2021-01-29) | -77.41% |
3 years (2020-01-30) | 4.96 |
5 years (2018-01-30) | 7.6 |
Cytosorbents Crp financials
Revenue TTM | $36.1 million |
---|---|
Gross profit TTM | $32.5 million |
Return on assets TTM | -26.97% |
Return on equity TTM | -75.36% |
Profit margin | -114.61% |
Book value | $0.90 |
Market capitalisation | $101.7 million |
TTM: trailing 12 months
Cytosorbents Crp share dividends
We're not expecting Cytosorbents Crp to pay a dividend over the next 12 months.
Have Cytosorbents Crp's shares ever split?
Cytosorbents Crp's shares were split on a 1:25 basis on 4 December 2014. So if you had owned 25 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Cytosorbents Crp shares – just the quantity. However, indirectly, the new 2400% higher share price could have impacted the market appetite for Cytosorbents Crp shares which in turn could have impacted Cytosorbents Crp's share price.
Cytosorbents Crp share price volatility
Over the last 12 months, Cytosorbents Crp's shares have ranged in value from as little as $1.03 up to $4.15. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cytosorbents Crp's is 0.5051. This would suggest that Cytosorbents Crp's shares are less volatile than average (for this exchange).
Cytosorbents Crp overview
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunctive therapy in other critical care applications, prevention and treatment of perioperative complications of cardiopulmonary bypass surgery, and maintaining or enhancing the quality of solid organs harvested from donors for organ transplant. The company also develops VetResQ, a device for adjunctive therapy in the treatment of sepsis, pancreatitis, and other critical illnesses in animals; CytoSorb-XL, a device for adjunctive therapy in the treatment of sepsis and other critical illnesses; HemoDefend blood purification technology platform to reduce contaminants in the blood supply that can cause transfusion reactions or disease when administering blood and blood products to patients, as well as removal of anti-A and anti-B blood group antibodies from fresh whole blood and plasma; K+ontrol for treatment of severe hyperkalemia in patients with life-threatening conditions; and ContrastSorb for the removal of IV contrast in blood administered during CT imaging, an angiogram, or during a vascular interventional radiology procedure to reduce the risk of contrast-induced nephropathy. In addition, it is involved in the development of BetaSorb, a device for the prevention and treatment of health complications caused by the accumulation of metabolic toxins in patients with chronic renal failure; DrugSorb, a device to remove toxic chemicals from the blood; and DrugSorb-ATR, an antithrombotic removal system. The company was formerly known as MedaSorb Technologies Corporation and changed its name to Cytosorbents Corporation in May 2010. Cytosorbents Corporation was founded in 1997 and is headquartered in Princeton, New Jersey. .
Cytosorbents Crp in the news
Cytosorbents Corporation's (NASDAQ:CTSO) market cap touched US$103m last week, benefiting both individual investors who own 52% as well as institutions
CytoSorbents Announces Health Canada Regulatory Approval For Pivotal STAR-T Trial
CytoSorbents Appoints Irina B. Kulinets, PhD, as Senior Vice President of Global Regulatory Affairs
Frequently asked questions
What percentage of Cytosorbents Crp is owned by insiders or institutions?Currently 9.859% of Cytosorbents Crp shares are held by insiders and 38.254% by institutions. How many people work for Cytosorbents Crp?
Latest data suggests 221 work at Cytosorbents Crp. When does the fiscal year end for Cytosorbents Crp?
Cytosorbents Crp's fiscal year ends in December. Where is Cytosorbents Crp based?
Cytosorbents Crp's address is: 305 College Road East, Princeton, NJ, United States, 08540 What is Cytosorbents Crp's ISIN number?
Cytosorbents Crp's international securities identification number is: US23283X2062 What is Cytosorbents Crp's CUSIP number?
Cytosorbents Crp's Committee on Uniform Securities Identification Procedures number is: 58404X107
More guides on Finder
-
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
-
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
-
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
-
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
-
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
-
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
-
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
-
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
-
How to research stocks
Learn about stock analysis and how to use it to find the right company to buy.
Ask an Expert